Advertisement
Expression of concern Free access | 10.1172/JCI62190
Find articles by Wang, F. in: JCI | PubMed | Google Scholar
Find articles by Okamoto, Y. in: JCI | PubMed | Google Scholar
Find articles by Inoki, I. in: JCI | PubMed | Google Scholar
Find articles by Yoshioka, K. in: JCI | PubMed | Google Scholar
Find articles by Du, W. in: JCI | PubMed | Google Scholar
Find articles by Qi, X. in: JCI | PubMed | Google Scholar
Find articles by Takuwa, N. in: JCI | PubMed | Google Scholar
Find articles by Gonda, K. in: JCI | PubMed | Google Scholar
Find articles by Yamamoto, Y. in: JCI | PubMed | Google Scholar
Find articles by Ohkawa, R. in: JCI | PubMed | Google Scholar
Find articles by Nishiuchi, T. in: JCI | PubMed | Google Scholar
Find articles by Sugimoto, N. in: JCI | PubMed | Google Scholar
Find articles by Yatomi, Y. in: JCI | PubMed | Google Scholar
Find articles by Mitsumori, K. in: JCI | PubMed | Google Scholar
Find articles by Asano, M. in: JCI | PubMed | Google Scholar
Find articles by Kinoshita, M. in: JCI | PubMed | Google Scholar
Find articles by Takuwa, Y. in: JCI | PubMed | Google Scholar
Published January 3, 2012 - More info
Sphingosine-1-phosphate (S1P) is a biologically active sphingolipid that has pleiotropic effects in a variety of cell types including ECs, SMCs, and macrophages, all of which are central to the development of atherosclerosis. It may therefore exert stimulatory and inhibitory effects on atherosclerosis. Here, we investigated the role of the S1P receptor S1PR2 in atherosclerosis by analyzing S1pr2–/– mice with an Apoe–/– background. S1PR2 was expressed in macrophages, ECs, and SMCs in atherosclerotic aortas. In S1pr2–/–Apoe–/– mice fed a high-cholesterol diet for 4 months, the area of the atherosclerotic plaque was markedly decreased, with reduced macrophage density, increased SMC density, increased eNOS phosphorylation, and downregulation of proinflammatory cytokines compared with S1pr2+/+Apoe–/– mice. Bone marrow chimera experiments indicated a major role for macrophage S1PR2 in atherogenesis. S1pr2–/–Apoe–/– macrophages showed diminished Rho/Rho kinase/NF-κB (ROCK/NF-κB) activity. Consequently, they also displayed reduced cytokine expression, reduced oxidized LDL uptake, and stimulated cholesterol efflux associated with decreased scavenger receptor expression and increased cholesterol efflux transporter expression. S1pr2–/–Apoe–/– ECs also showed reduced ROCK and NF-κB activities, with decreased MCP-1 expression and elevated eNOS phosphorylation. Pharmacologic S1PR2 blockade in S1pr2+/+Apoe–/– mice diminished the atherosclerotic plaque area in aortas and modified LDL accumulation in macrophages. We conclude therefore that S1PR2 plays a critical role in atherogenesis and may serve as a novel therapeutic target for atherosclerosis.
Fei Wang, Yasuo Okamoto, Isao Inoki, Kazuaki Yoshioka, Wa Du, Xun Qi, Noriko Takuwa, Koichi Gonda, Yasuhiko Yamamoto, Ryunosuke Ohkawa, Takumi Nishiuchi, Naotoshi Sugimoto, Yutaka Yatomi, Kunitoshi Mitsumori, Masahide Asano, Makoto Kinoshita, Yoh Takuwa
Original citation: J. Clin. Invest. 2010;120(11):3979–3995. doi:10.1172/JCI42315.
Citation for this expression of concern: J. Clin. Invest. 2012;122(1):419. doi:10.1172/JCI62190.
First published October 18, 2010.
Several figures in this study appear to be inaccurately portrayed, and the authors are not currently able to furnish the raw data. Kanazawa University is conducting an investigation into potential scientific misconduct in the performance of this study. We will inform our readers of the outcome of this investigation when it is complete.